Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chaimovitz

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Kidney International|June 1, 1992
Acute phosphate depletion and in vitro rat proximal tubule injury: protection by glycine and acidosisA R Almeida, J F Wetzels, D Bunnachak, et al.
Nephron|January 1, 1991
Oral administration of 24,25(OH)2D3 suppresses the serum parathyroid hormone levels of dialysis patientsD Ben-Ezer, S Shany, A Conforty, et al.
Bone|January 1, 1992
Assessment of combined 24,25(OH)2D3 and 1 alpha (OH)D3 therapy for bone disease in dialysis patientsM M Popovtzer, J Levi, Y Bar-Khayim, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Kidney International|June 1, 1992
Acute phosphate depletion and in vitro rat proximal tubule injury: protection by glycine and acidosisA R Almeida, J F Wetzels, D Bunnachak, et al.
Nephron|January 1, 1991
Oral administration of 24,25(OH)2D3 suppresses the serum parathyroid hormone levels of dialysis patientsD Ben-Ezer, S Shany, A Conforty, et al.
Bone|January 1, 1992
Assessment of combined 24,25(OH)2D3 and 1 alpha (OH)D3 therapy for bone disease in dialysis patientsM M Popovtzer, J Levi, Y Bar-Khayim, et al.
Pageof 11